# EMORY UNIVERSITY: A Phase 2b randomized open label trial to assess the quality and balance of dengue immunity elicited by prime-boost combinations of TAK-003 and Butantan-DV

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | EMORY UNIVERSITY |
| Location | ATLANTA, GA |
| Project | A Phase 2b randomized open label trial to assess the quality and balance of dengue immunity elicited by prime-boost combinations of TAK-003 and Butantan-DV |
| Project number | 3U01AI186860-02S1 |
| Mechanism | U01 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $317,520 |
| Awarded | 2026-08-27 |
| Project period | 2025-09-19 to 2030-07-31 |
| UEI | S352L5PJLMP8 |

## Why this score
- Award of $317,520.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11590657). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.